Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.

Wake, Mayumi; Oh, Akinori; Onishi, Yoshie; Guelfucci, Florent; Shimasaki, Yukio; Teramoto, Tamio

Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.

Wake, Mayumi; Oh, Akinori; Onishi, Yoshie; Guelfucci, Florent; Shimasaki, Yukio; Teramoto, Tamio.

Affiliation

Wake M; Japan Medical Affairs, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan.
Oh A; Japan Medical Affairs, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan.
Onishi Y; Creativ-Ceutical K.K., Tokyo, Japan.
Guelfucci F; Health Economics and Outcome Research, Creativ-Ceutical, Paris, France.
Shimasaki Y; Japan Medical Affairs, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan.
Teramoto T; Teikyo Academic Research Center, Teikyo University, Tokyo, Japan. Electronic address: ttera@med.teikyo-u.ac.jp.

Atherosclerosis ; 282: 19-28, 2019 03.

Article in En | MEDLINE | ID: mdl-30669019

Subject(s)
Key words

Adherence; Cardiovascular disease; Diabetes mellitus; Hyperlipidemia; Persistence

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Atherosclerosis / Medication Adherence / Hyperlipidemias Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Atherosclerosis Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Irlanda

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google